Global Type-2 Diabetes Market to Hit USD 72.21 Billion by 2030

• Overview
• Table of Content
• Research Methodology
• Download Free Sample

The Global Type-2 Diabetes Market size was valued at around USD 52.7 billion in 2024 and is expected to reach USD 72.21 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 5.39% during the forecast period, i.e., 2025-30, cites MarkNtel Advisors in the recent research report.

The market growth is primarily propelled by the growing population of type 2 diabetes resulting from unhealthy lifestyles, physical inactivity, and obesity. Thus, the number of diabetes cases is increasing day by day. According to the World Health Organization (WHO), nearly 422 million people globally have diabetes, with the majority of people from low and middle-income countries. This has led to the introduction of medical substances, creating potential for new treatments such as DPP4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, Colesevelam, and bromocriptine QR. The intake of these substances has led to exponential growth of the type 2 diabetes market.

Furthermore, key players in the market have brought forth advanced medical devices to cure diabetic patients. They have also entered the digital market by launching mobile health apps to ease the tracking of type 2 diabetes. The launching of biosimilar pharmaceuticals is also rapidly rising, further expanding the market. These key players are also allying with other pharmaceutical firms to offer products and gain a competitive edge in the market. All these factors mentioned above accentuate the market in the coming years, further states the research report, “Global Type-2 Diabetes Market Analysis, 2025.”

Global Type-2 Diabetes Market Segmentation Analysis

Multiple Pregnancy Outcomes Drive the Female Segment

Based on the Gender segment, the market is further bifurcated into Male and Female

The female segment is anticipated to have the largest market share due to the prevalence of type 2 diabetes among pregnant women. The development of gestational diabetes is high among pregnant women due to multiple pregnancy outcomes. Additionally, there is a high chance of developing type 2 diabetes every three to six years after delivery. Moreover, exposure to hyperglycemia in the womb affects the health of the child, resulting in overweight and an increased prone of type 2 diabetes. Hence, these factors are essentially fueling the type 2 diabetes market.

Increasing Rate of Chronic Diseases Fuels the Type-2 Diabetes Market in North America

North America is predicted to drive market growth in the forecasted time frame. This is mainly attributed to the increasing rate of obesity, cardiovascular, and chronic diseases in the country, resulting in type 2 diabetes in people. According to the Centers for Disease Control and Prevention, diabetes negatively impacts nearly 37 million Americans, with type 2 diabetes accounting for 90-95% of cases. It predominantly affects those over 45, along with a growing tendency in adolescents, teenagers, and young adults. These aspects are likely to influence the market positively in the coming years.

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market players, including Merck & Co, AstraZeneca, Novo Nordisk. Bristol-Myers Squibb, Eli Lilly, Sanofi, Boehringer Ingelheim, Pfizer, Takeda, Biocon, Johnson & Johnson and others are looking forward to strengthening their market position.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the region?
4. How has the industry been evolving in terms of geography & product adoption?
5. How has the competition been shaping across various countries?
6. How has the buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2020-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?